Clinical trial
Metabolic Impact of Intermittent Fasting in Early Type 2 Diabetes
NCT05717127 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolic Impact of Intermittent Fasting in Early Type 2 Diabetes
- Lead sponsor
- Mount Sinai Hospital, Canada
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- June 1, 2023
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.